| Matthew Michael Levitsky, MD | |
|
1350 Tamiami Trl N Ste 203, Naples, FL 34102-5209 | |
| (239) 325-1131 | |
| (239) 262-5980 |
| Full Name | Matthew Michael Levitsky |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 7 Years |
| Location | 1350 Tamiami Trl N Ste 203, Naples, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083145924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2022-01092 (North Carolina) | Secondary |
| 207X00000X | Orthopaedic Surgery | ME163907 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Philip Regala Md Pl | 4587625728 | 2 |
News Archive
It's time to expand the models for blood pressure regulation, according to clinical pharmacologist Jens Titze, M.D. Titze and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.
Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.
Scientists from the US and Germany have recently evaluated the efficacy of an mRNA-based COVID-19 vaccine candidate, CV07050101, in inducing humoral and cellular immune responses in non-human primates. The study reveals that prime-boost immunization with the vaccine candidate induces only limited immunity against SARS-CoV-2.
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD).
› Verified 4 days ago
| Entity Name | Philip Regala Md Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861538902 PECOS PAC ID: 4587625728 Enrollment ID: O20041021000546 |
News Archive
It's time to expand the models for blood pressure regulation, according to clinical pharmacologist Jens Titze, M.D. Titze and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.
Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.
Scientists from the US and Germany have recently evaluated the efficacy of an mRNA-based COVID-19 vaccine candidate, CV07050101, in inducing humoral and cellular immune responses in non-human primates. The study reveals that prime-boost immunization with the vaccine candidate induces only limited immunity against SARS-CoV-2.
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Michael Levitsky, MD 1350 Tamiami Trl N Ste 203, Naples, FL 34102-5209 Ph: (239) 325-1131 | Matthew Michael Levitsky, MD 1350 Tamiami Trl N Ste 203, Naples, FL 34102-5209 Ph: (239) 325-1131 |
News Archive
It's time to expand the models for blood pressure regulation, according to clinical pharmacologist Jens Titze, M.D. Titze and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.
Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.
Scientists from the US and Germany have recently evaluated the efficacy of an mRNA-based COVID-19 vaccine candidate, CV07050101, in inducing humoral and cellular immune responses in non-human primates. The study reveals that prime-boost immunization with the vaccine candidate induces only limited immunity against SARS-CoV-2.
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD).
› Verified 4 days ago
Herbert S Gates Iii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 681 Goodlette Rd Ste 220, Naples, FL 34102 Phone: 239-263-4511 Fax: 239-263-5562 | |
Dr. Richard J De Asla, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1285 Creekside Blvd East, Suite 102, Naples, FL 34109 Phone: 239-624-0310 Fax: 239-624-0311 | |
Courtney Bell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 Pine Ridge Rd Ste 202, Naples, FL 34108 Phone: 239-325-1135 | |
James M. Ray, M.D. Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 7385 Radio Rd Ste 104, Naples, FL 34104 Phone: 239-384-9392 Fax: 239-294-7252 | |
Patrick Wakefield Joyner, M.D., M.S. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1250 Pine Ridge Rd Ste 202, Naples, FL 34108 Phone: 239-325-1135 Fax: 239-262-3843 | |
Dr. Philip T Regala, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Tamiami Trl N, Ste 203, Naples, FL 34102 Phone: 239-325-1131 Fax: 239-262-5980 |